Piper Sandler last night upgraded Upstart (UPST) to Overweight from Neutral with a price target of $85, up from $31. The company will benefit ...

SolarEdge Technologies rebounds after Trump administration fears, but Q3 loss and forecasted revenue decline raise concerns.

Piper Sandler downgraded HubSpot (HUBS) to Neutral from Overweight with a price target of $640, up from $570. The firm is encouraged by the ...

Expectations for President-elect Donald Trump to roll out expansionary fiscal policies and extend U.S. economic ...

Piper Sandler raises Fastly target to $8; keeps Neutral rating. Fastly's Q3 EPS beats estimates, revenue slightly misses ...

Celanese downgraded at Piper Sandler, citing uncertain business environment and financial strain ahead with a precarious condition of the balance sheet.

Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for ...

Such findings raised questions about the added benefit of masofaniten, leading ESSA to abandon the drug’s development. In light of these results, Piper Sandler removed any projected value for ...

Piper Sandler Companies (NYSE:PIPR – Get Free Report) last issued its quarterly earnings data on Friday, October 25th.The financial services provider reported $2.57 earnings per share for the ...

On Tuesday, Piper Sandler began coverage of CAMP4 Therapeutics Corp (NASDAQ:CAMP) stock with an Overweight rating and a price target of $18.00. The firm highlighted CAMP4's innovative work in the ...

Piper Sandler initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $18 price target The company is is pioneering development of regulatory RNAs as a novel therapeutic ...

Piper Sandler analysts on Thursday cut their rating on HubSpot (NYSE:HUBS) shares to Neutral from Overweight, while raising ...